Risk-Benefit Analysis: From a Logical Point of View

被引:0
作者
Georg Spielthenner
机构
[1] The University of Zambia,Department of Philosophy and Applied Ethics
来源
Journal of Bioethical Inquiry | 2012年 / 9卷
关键词
Risk–benefit analysis; Absolute risks/benefits; Incremental risks/benefits; Medical decision-making; Practical reasoning;
D O I
暂无
中图分类号
学科分类号
摘要
In this paper I am concerned with risk–benefit analysis; that is, the comparison of the risks of a situation to its related benefits. We all face such situations in our daily lives and they are very common in medicine too, where risk–benefit analysis has become an important tool for rational decision-making. This paper explores risk–benefit analysis from a logical point of view. In particular, it seeks a better understanding of the common view that decisions should be made by weighing risks against benefits and that an option should be chosen if its benefits outweigh its risks. I devote a good deal of this paper scrutinizing this popular view. Specifically, I demonstrate that this mode of reasoning is logically faulty if “risk” and “benefit” are taken in their absolute sense. But I also show that arguing in favour of an action because its benefits outweigh its risks can be valid if we refer to incremental risks and benefits.
引用
收藏
页码:161 / 170
页数:9
相关论文
共 43 条
[1]  
Allen BR(2002)Risk:benefit ratio is important in treating atopic dermatitis British Medical Journal 325 970-1500
[2]  
Luger TA(1994)Costs outweigh benefits British Medical Journal 309 1499-641
[3]  
Allison SP(1996)Thrombolysis in acute stroke: Defining the risk to benefit ratio for individual patients remains impossible British Medical Journal 313 640-331
[4]  
Bogousslavsky J(1998)Double effect: Does it have a proper use in palliative care? Journal of Palliative Medicine 1 329-733
[5]  
Brody H(2006)A public health perspective on research ethics Journal of Medical Ethics 32 729-6
[6]  
Buchanan DR(2002)Balancing the risks and benefits of moderate drinking Annals of the New York Academy of Science 957 1-334
[7]  
Miller FG(1983)The doctrine of logic as form Linguistics and Philosophy 6 319-2000
[8]  
Ellison RC(1999)Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial The Lancet 353 1993-930
[9]  
Etchemendy J(2000)Why is cost–benefit analysis so controversial? The Journal of Legal Studies 29 913-17
[10]  
Fisher B(1978)Depo: Do the benefits outweigh the risks? International Family Planning Perspectives and Digest 4 65-183